A rollover phase II study testing the biologic activity

  • Gupta, Shilpa (PI)
  • Dudek, Arkadiusz Z (Prior Principal Investigator)
  • Jha, Gautam (Prior Principal Investigator)

Project: Research project

Project Details

Description

A rollover phase II study testing the biologic activity and safety of AGS-003 in renal cell carcinoma subjects with prolonged response or stable disease and ongoing AGS-003 treatment in protocol AGS-003- 004 or AGS-003-006
StatusFinished
Effective start/end date11/1/1111/1/18

Funding

  • Argos Therapeutics, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.